Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 7:49 PM ET

Healthcare Equipment and Supplies

Company Overview of CardioFocus, Inc.

Company Overview

CardioFocus, Inc. develops an endoscopic ablation system for the treatment of cardiac disorders (atrial fibrillation) in the United States. CardioFocus, Inc. was formerly known as Rare Earth Medical, Inc. and changed its name to CardioFocus, Inc. in June 1999. The company was incorporated in 1990 and is based in Marlborough, Massachusetts.

500 Nickerson Road

Suite 500-200

Marlborough, MA 01752

United States

Founded in 1990





Key Executives for CardioFocus, Inc.

Chief Executive Officer, President and Director
Executive Chairman
Age: 57
Founder and Chief Technology Officer
Chief Financial Officer and Treasurer
Vice President of Operations
Compensation as of Fiscal Year 2015.

CardioFocus, Inc. Key Developments

CardioFocus, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:20 PM

CardioFocus, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:20 PM. Venue: Westin Grand Central, New York, New York, United States.

CardioFocus, Inc. Partners with Japan Lifeline Co., Ltd. for Distribution of the HeartLight Laser Balloon to Treat Atrial Fibrillation

CardioFocus, Inc. announced that it has executed an exclusive, multi-year distribution agreement with Japan Lifeline Co., Ltd. Atrial fibrillation (AF) is the most common sustained arrhythmia and presents elevated risk factors for both stroke and death. It is estimated that more than 1 million people in Japan currently suffer from this debilitating disease. Individuals affected by AF have been increasing worldwide due to an aging population and continued increases in the prevalence and incidence of AF are expected.

CardioFocus Announces HeartLight(R) Now Available in Spain for the Treatment for Atrial Fibrillation

CardioFocus, Inc. announced that its technology is now available in Spain for clinical use. Physicians at Hospital Universitari i Politecnic La Fe in Valencia were the first in the country to offer the innovative catheter ablation technology for the treatment of AF, the most common heart rhythm disorder in the world. The HeartLight EAS is the first catheter ablation system to incorporate an endoscope for direct visualization of the pulmonary vein in a beating heart, in real time and without radiation. It also includes a compliant balloon catheter designed for improved contact with the area surrounding the pulmonary veins, irrespective of individual patient anatomy, and a laser energy source designed to deliver more efficient, precise, and durable ablation treatment.

Similar Private Companies By Industry

Company Name Region
ivWatch, LLC United States
CardiAQ Valve Technologies, Inc. United States
Sunscope Inc. United States
InaVein, LLC United States
EiRx Pharmaceutical Limited United States

Recent Private Companies Transactions

Private Placement
December 22, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CardioFocus, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at